Yes, midazolam is a Schedule IV controlled substance under the U.S. Controlled Substances Act. It carries the DEA code number 2884 and is also listed as a Schedule IV substance internationally under the United Nations Convention on Psychotropic Substances of 1971. This places it in the same regulatory category as other well-known benzodiazepines like alprazolam (Xanax) and diazepam (Valium).
What Schedule IV Means
The DEA uses a five-tier scheduling system, with Schedule I being the most restrictive and Schedule V the least. Schedule IV drugs are defined as having a low potential for abuse relative to Schedule III substances, an accepted medical use in the United States, and a risk of limited physical or psychological dependence. In practical terms, this means midazolam requires a prescription, and healthcare facilities that stock it must follow specific record-keeping, storage, and disposal rules enforced by the DEA.
If midazolam is left behind or abandoned by a patient at a medical facility, DEA regulations do not allow practitioners to simply throw it away. They are directed to contact state or local law enforcement, or their local DEA office, for guidance on proper disposal. These rules apply to all controlled substances in Schedules II through V.
Why Midazolam Is Controlled
Midazolam is a benzodiazepine, and like all drugs in that class, it works by enhancing the activity of a natural brain chemical called GABA. Rather than replacing GABA, midazolam makes GABA bind more effectively to its receptor, which amplifies the brain’s own calming signals. The result is sedation, reduced anxiety, and suppression of seizure activity.
That mechanism is what makes midazolam medically useful, but it also creates potential for misuse. Animal studies have shown that monkeys will self-administer midazolam intravenously, a classic marker of a drug’s reinforcing properties. In humans, abuse has been documented as well. One factor that raises concern is how quickly midazolam reaches peak blood levels depending on the route. When taken through the nose, for example, it reaches the bloodstream almost as fast as an intravenous injection, and faster onset generally increases a drug’s appeal to recreational users. Research on cocaine users found that people with a history of nasal drug use were more likely to find nasal midazolam reinforcing, though the drug itself did not appear to pose significant abuse risk in people without that history.
Physical dependence can develop with regular use. As with other benzodiazepines, stopping abruptly after prolonged use can trigger withdrawal symptoms, which is one reason the drug’s availability is restricted.
How Midazolam Is Used Medically
Midazolam is primarily a hospital and clinical-setting drug. Its FDA-approved uses include continuous sedation for patients on mechanical ventilators in intensive care, and it is widely used as a component of anesthesia. You are unlikely to encounter it as a take-home prescription the way you might with alprazolam or lorazepam. It is most often given by injection or intravenous infusion, though nasal spray formulations exist for emergency seizure treatment.
Because of the setting in which it is used, midazolam comes with strict administration requirements. It must be given by trained personnel who can manage serious respiratory and cardiac complications, and patients need continuous monitoring of breathing and heart function until they are stable. Resuscitation equipment and drugs must be immediately available.
Serious Safety Risks
Midazolam carries significant warnings about respiratory depression, meaning it can slow or stop breathing. This risk is highest in people over 60, those with chronic lung conditions like COPD, and anyone taking opioids, barbiturates, or alcohol at the same time. Combining benzodiazepines with opioids can cause profound sedation, respiratory failure, coma, and death.
Serious cardiorespiratory events, including airway obstruction, oxygen desaturation, respiratory arrest, and cardiac arrest, have occurred after midazolam administration. Some of these cases resulted in death or permanent brain injury. These risks are a major reason the drug is restricted to monitored medical environments rather than prescribed for home use in most situations.
How It Compares to Other Benzodiazepines
Every benzodiazepine currently approved in the United States is classified as Schedule IV. That includes commonly prescribed drugs like alprazolam (Xanax), diazepam (Valium), lorazepam (Ativan), and clonazepam (Klonopin). So midazolam does not carry a stricter or more lenient classification than its relatives. The key difference is in how it is used: most other Schedule IV benzodiazepines are routinely dispensed as outpatient prescriptions for anxiety or insomnia, while midazolam is overwhelmingly administered in hospitals and procedural settings where its rapid onset and short duration are most useful.